Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma.
about
TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival.A Comparative Analysis of Genetic and Epigenetic Events of Breast and Ovarian Cancer Related to TumorigenesisGene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer.TP53 mutations in human cancers: origins, consequences, and clinical usePrognostic biomarkers in ovarian cancer.High levels of genomic aberrations in serous ovarian cancers are associated with better survival.Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population.Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies.Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment.Prognostic value of the TP53 Arg72Pro single-nucleotide polymorphism and susceptibility to medulloblastoma in a cohort of Brazilian patients.Geographical variations in TP53 mutational spectrum in ovarian carcinomas.Mutation Analysis of TP53 Tumor Suppressor Gene in Colorectal Cancer in Patients from Iran (Kerman Province).A Case-Control Study of TP53 R72P Polymorphism in the Breast Cancer Patients of Ethnic Kashmiri Population.Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk.
P2860
Q24812743-222FF20C-1EDA-4696-B2C0-8362C7B95D2FQ26746952-BBBC185F-FFE3-4BFD-8B5B-75D96F617224Q33261025-9D309995-D9CA-46D8-85DB-24A0E7C98DD2Q33685392-BE8420EF-9AA2-4E6E-AA52-17F1A1A5766EQ34086636-0BAC18E5-4709-426F-BDE5-D87C87515975Q34571142-F5F18C53-A3D1-415D-B669-1AF58E9ECBF1Q35984539-B508F21B-34FE-4378-BB78-1573CA21A9EEQ36612301-1141F2E4-9CC7-44A4-9397-18B7924918DFQ37293815-B56E516B-83A7-4B4C-8DF3-39560C5D046BQ39570440-EC7414A6-455D-46C4-A4C4-46A74D7EDA3BQ42595284-9C979F1D-CBA2-46B0-9117-430943417FE7Q43236627-30A05893-385C-45D0-B92E-D74AE12F16DBQ47134005-AE9C0C05-A25F-450E-9A8E-E9DB19163DA6Q53089359-1FED9551-3BB0-4FE8-AC57-E52A66CBD64F
P2860
Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Effect of the codon 72 polymor ...... th advanced ovarian carcinoma.
@en
Effect of the codon 72 polymor ...... th advanced ovarian carcinoma.
@nl
type
label
Effect of the codon 72 polymor ...... th advanced ovarian carcinoma.
@en
Effect of the codon 72 polymor ...... th advanced ovarian carcinoma.
@nl
prefLabel
Effect of the codon 72 polymor ...... th advanced ovarian carcinoma.
@en
Effect of the codon 72 polymor ...... th advanced ovarian carcinoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
Effect of the codon 72 polymor ...... th advanced ovarian carcinoma.
@en
P2093
Gunnar B Kristensen
Hanne Skomedal
Magali Olivier
Mark M O Baekelandt
Pedro Kringen
Vera M Abeler
P2860
P356
10.1002/HUMU.20055
P577
2004-07-01T00:00:00Z